| Property | Value |
|
keywords
|
Metabolic tumor burden; metabolic tumor volume ; non-small cell lung cancer; FDG, PET/CT.
|
|
overview
|
I am a board certified nuclear radiologist by the American Board of Nuclear Medicine, American Board of Radiology and American Board of Nuclear Cardiology. I am a reviewer of 16 international journals including Journal of Nuclear Medicine; European Journal of Nuclear Medicine and Molecular Imaging; Proceedings of the National Academy of Sciences (PNAS); International Journal of Computer Assisted Radiology and Surgery; PLOS ONE; Academic Radiology; Cancer Control Journal: Journal of the Moffitt Cancer Center; Medical Physics; International Journal of Radiation Oncology, Biology, Physics; Theranostics and Lung Cancer Management published by Future Medicine. I am an editorial board member of Chinese Journal of Cancer Research. I am also a reviewer of the Self-Assessment Module (SAM) for the American Board of Radiology.
My research experience includes metabolic tumor imaging and quantification from FDG PET/CT imaging, and the impact of metabolic tumor burden on the long-term outcomes of patients with non-small cell lung cancer (NSCLC). I was the contact co-PI of an NIH (NCI) funded R21 project for developing the new PET volumetric prognostic (PVP) staging for NSCLC. My research experience also includes brain functional imaging and brain MRS as well as computer-aided diagnosis in PET/CT and bone scintigraphy.
I have authored and co-authored more than 60 original peer-reviewed scientific research papers, six peer-reviewed proceeding papers, two non-peer-reviewed letters to editors and five non-peer-reviewed review papers in the field of medicine. I am the senior corresponding author of the article [Eur J Nucl Med Mol Imaging, 2012; 39(1): 27-38. https://www.ncbi.nlm.nih.gov/pubmed/21946983] that won the Springer Award in 2016 for the Most Cited Paper of the Eur J Nucl Med Mol Imaging (https://link.springer.com/article/10.1007/s00259-016-3538-7).
|